Anzeige
Mehr »
Donnerstag, 18.12.2025 - Börsentäglich über 12.000 News
Breaking News: Übernahme von Weltraum-Technologie ins Portfolio?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrFDA endorses 2nd new gonorrhea treatment, clearing way for Innoviva's Nuzolvence
FrGSK's long-acting asthma med scores in suite of CHMP drug endorsements
FrNew CDC report backs COVID vaccine effectiveness in children as vaccine safety probe heats up at FDA
FrNanoVibronix feeds into new focus on ENvue enteral system with rebrand
FrGSK gains FDA expansion for Blujepa to treat gonorrhea
FrAmgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod
FrFierce Pharma Asia-Pfizer, Zealand metabolic disease deals; China's 1st private insurance formulary
11.12.European legislators reach agreement on sweeping overhaul to pharma policies
11.12.Geron to lay off third of workforce in bid to slash operating costs
11.12.Abbott teams up with Serena Williams again in Lingo CGM push
11.12.Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
11.12.Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by year-end: Bloomberg
10.12.FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says
10.12.CDMO Adare plots 137 layoffs in Philly shortly after transplanting headquarters from N.J.
10.12.AstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study
10.12.FDA awards 1st national priority nod to USAntibiotics' Augmentin XR
10.12.In win for pharma, UK cuts medicine rebate rate following US intervention
10.12.FDA finalizes guidance on promotional materials for biologics and biosimilars
10.12.Italian nonprofit lands FDA approval for first gene therapy to treat rare genetic disease
10.12.After deal spree, Supreme Group unites agencies to form new PR and communications group
09.12.CDMOs Bora, Corealis link up to provide one-stop shop for oral solid dose production, development
09.12.Genentech uncovers 'Hidden GeMS' in latest iteration of multiple sclerosis visibility drive
09.12.Roll Tide: Lilly selects Alabama site as location for $6B API facility
09.12.Biocon buys out Viatris and others from biosimilar subsidiary
09.12.FDA now has Merck, AstraZeneca and Sanofi RSV shots for infants in its crosshairs: Reuters